arginyl-glycyl-aspartic acid has been researched along with rusalatide acetate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Flordellis, CS; Maragoudakis, ME; Papaconstantinou, ME; Tsopanoglou, NE | 1 |
Cheung-Flynn, J; Derkach, DN; Dreiza, CM; Perkins, KB; Ramos, HC; Rousseau, E; Sheller, MR; Ugarova, TP; Wadekar, SA | 1 |
2 other study(ies) available for arginyl-glycyl-aspartic acid and rusalatide acetate
Article | Year |
---|---|
On the mode of action of thrombin-induced angiogenesis: thrombin peptide, TP508, mediates effects in endothelial cells via alphavbeta3 integrin.
Topics: Cell Adhesion; Cell Movement; Endothelium, Vascular; Humans; Integrins; MAP Kinase Signaling System; Neovascularization, Physiologic; Oligopeptides; Peptide Fragments; Receptors, Vitronectin; Thrombin; Umbilical Veins | 2004 |
RGD-dependent binding of TP508 to integrin alphavbeta3 mediates cell adhesion and induction of nitric oxide.
Topics: Animals; Antibodies, Blocking; Aorta; Carbachol; Cell Adhesion; Cell Line; Endothelial Cells; Focal Adhesion Kinase 2; Humans; Integrin alphaVbeta3; Male; Mitogen-Activated Protein Kinase 3; Nitric Oxide; Oligopeptides; Peptide Fragments; Protein Binding; Rats; Rats, Sprague-Dawley; Thrombin; Vasodilation | 2010 |